Many young patients with cancer may not be informed of fertility preservation options
the ONA take:
Many young patients with cancer may have limited knowledge of fertility preservation options, according to a new study published online ahead of print in the journal Cancer.
For the study, researchers surveyed 459 adolescents and young adults who were diagnosed with cancer in 2007 and 2008.
Researchers found that more than 70% of those reported being informed that cancer treatment may affect their fertility; however, males were more than twice as likely as females to report being told about fertility preservation options and males were almost five times as likely as female patients to make fertility preservation arrangements.
Researchers found that patient socioeconomic status medical factors, and child-rearing status were associated with whether a discussion on fertility preservation options occurred.
"The access and health-related reasons for not making arrangements for fertility preservation reported by participants in this study further highlight the need for decreased cost, improved insurance coverage, and partnerships between cancer healthcare providers and fertility experts to develop strategies that increase awareness of fertility preservation options and decrease delays in cancer therapy as fertility preservation for adolescent and young adult cancer patients improves," said Margarett Shnorhavorian, MD, MPH, FAAP, FACS, of the University of Washington, Seattle Children's Hospital.
Many young patients with cancer may have limited knowledge of fertility preservation options.
Sign Up for Free e-newsletters
- Fluorouracil Associated With Reduced Surgery for Squamous Cell Carcinoma
- Incidence of Post-traumatic Stress Disorder High Among Patients With Cancer
- Long-Term Night Shift Work Associated With Cancer Risk in Women
- Distress, Neuroticism Predict Long-term Emotional Distress After Cancer Diagnosis
- FDA Grants Breakthrough Therapy Designation to Lenvatinib Plus Pembrolizumab for RCC
- Bacteria in Probiotics Carry Potential Risks for Immunocompromised Patients
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Patient Satisfaction Ratings Can Be Negatively Impacted by Nurse Staffing Ratio
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- Comparison of Survival Outcomes Between Radical Hysterectomy and Definitive Radiochemotherapy in Stage IB1 and IIA1 Cervical Cancer
- Fosfomycin Effective Alternate for Febrile Neutropenia Prophylaxis
- Adherence to Skin Cancer Screening Guidelines Beneficial in Management SCC in SOTRs
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|